Concepts (253)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nanoparticles | 11 | 2021 | 446 | 3.530 |
Why?
|
| Polyglycolic Acid | 7 | 2017 | 16 | 2.970 |
Why?
|
| Lactic Acid | 6 | 2017 | 66 | 2.750 |
Why?
|
| Glioblastoma | 6 | 2022 | 131 | 2.620 |
Why?
|
| Brain Neoplasms | 7 | 2023 | 232 | 2.260 |
Why?
|
| Drug Delivery Systems | 7 | 2021 | 273 | 1.810 |
Why?
|
| Brain | 8 | 2023 | 1193 | 1.480 |
Why?
|
| Tissue Scaffolds | 4 | 2017 | 75 | 1.220 |
Why?
|
| Blood-Brain Barrier | 5 | 2023 | 67 | 1.170 |
Why?
|
| Hydrogels | 4 | 2016 | 90 | 1.140 |
Why?
|
| Camptothecin | 2 | 2015 | 18 | 1.090 |
Why?
|
| Drug Carriers | 4 | 2017 | 156 | 1.040 |
Why?
|
| Positron-Emission Tomography | 3 | 2014 | 139 | 0.980 |
Why?
|
| Cerebellar Neoplasms | 1 | 2023 | 8 | 0.980 |
Why?
|
| Medulloblastoma | 1 | 2023 | 12 | 0.970 |
Why?
|
| Polyethylene Glycols | 3 | 2019 | 161 | 0.870 |
Why?
|
| Estradiol | 4 | 2017 | 252 | 0.850 |
Why?
|
| Tumor Microenvironment | 2 | 2023 | 117 | 0.820 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2021 | 27 | 0.810 |
Why?
|
| beta-Cyclodextrins | 1 | 2021 | 24 | 0.810 |
Why?
|
| Cell Line, Tumor | 9 | 2022 | 1256 | 0.790 |
Why?
|
| Cell Proliferation | 3 | 2017 | 894 | 0.770 |
Why?
|
| Animals | 26 | 2023 | 17887 | 0.770 |
Why?
|
| Acrylic Resins | 2 | 2017 | 18 | 0.760 |
Why?
|
| Neoplastic Stem Cells | 2 | 2022 | 187 | 0.740 |
Why?
|
| Polystyrenes | 1 | 2019 | 31 | 0.720 |
Why?
|
| Spinal Cord | 1 | 2019 | 121 | 0.700 |
Why?
|
| Paclitaxel | 2 | 2009 | 62 | 0.700 |
Why?
|
| Hydroxamic Acids | 1 | 2018 | 23 | 0.660 |
Why?
|
| Tissue Culture Techniques | 1 | 2018 | 26 | 0.650 |
Why?
|
| Cell Culture Techniques | 2 | 2017 | 169 | 0.640 |
Why?
|
| Organ Specificity | 1 | 2018 | 168 | 0.630 |
Why?
|
| Hormone Replacement Therapy | 1 | 2017 | 32 | 0.620 |
Why?
|
| Cell-Penetrating Peptides | 1 | 2017 | 27 | 0.600 |
Why?
|
| Tissue Engineering | 2 | 2015 | 131 | 0.600 |
Why?
|
| Tissue Distribution | 5 | 2018 | 227 | 0.590 |
Why?
|
| Central Nervous System | 2 | 2023 | 143 | 0.560 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2013 | 110 | 0.540 |
Why?
|
| Fluorine Radioisotopes | 1 | 2014 | 6 | 0.530 |
Why?
|
| Menopause | 1 | 2017 | 236 | 0.520 |
Why?
|
| Mice | 11 | 2023 | 9258 | 0.510 |
Why?
|
| Temperature | 1 | 2015 | 281 | 0.500 |
Why?
|
| Glioma | 1 | 2015 | 89 | 0.500 |
Why?
|
| Leydig Cell Tumor | 1 | 2013 | 1 | 0.490 |
Why?
|
| Vitamin E | 1 | 2013 | 52 | 0.480 |
Why?
|
| Testicular Neoplasms | 1 | 2013 | 28 | 0.480 |
Why?
|
| Radiopharmaceuticals | 1 | 2013 | 140 | 0.460 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2015 | 76 | 0.460 |
Why?
|
| Mice, Inbred C57BL | 7 | 2021 | 2908 | 0.460 |
Why?
|
| Adrenal Glands | 2 | 2003 | 31 | 0.440 |
Why?
|
| src-Family Kinases | 2 | 2003 | 56 | 0.430 |
Why?
|
| Subarachnoid Space | 2 | 2023 | 9 | 0.430 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 3 | 2021 | 225 | 0.390 |
Why?
|
| Styrenes | 1 | 2009 | 4 | 0.380 |
Why?
|
| Injections, Spinal | 2 | 2020 | 33 | 0.370 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2010 | 37 | 0.370 |
Why?
|
| Rats | 7 | 2021 | 1675 | 0.370 |
Why?
|
| Drug-Eluting Stents | 1 | 2009 | 30 | 0.360 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2009 | 39 | 0.360 |
Why?
|
| Apoptosis | 2 | 2017 | 975 | 0.350 |
Why?
|
| Antineoplastic Agents | 3 | 2021 | 526 | 0.340 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2014 | 504 | 0.330 |
Why?
|
| Hippocampus | 1 | 2010 | 203 | 0.330 |
Why?
|
| Arteries | 1 | 2008 | 63 | 0.330 |
Why?
|
| Antidepressive Agents | 1 | 2010 | 212 | 0.330 |
Why?
|
| Humans | 16 | 2023 | 50800 | 0.320 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2021 | 164 | 0.310 |
Why?
|
| Cell Survival | 4 | 2017 | 520 | 0.310 |
Why?
|
| Chemokine CXCL12 | 2 | 2016 | 14 | 0.290 |
Why?
|
| Biological Transport | 2 | 2020 | 265 | 0.290 |
Why?
|
| Laminin | 2 | 2016 | 76 | 0.280 |
Why?
|
| Hyaluronic Acid | 2 | 2016 | 47 | 0.280 |
Why?
|
| Tumor Cells, Cultured | 2 | 2017 | 397 | 0.280 |
Why?
|
| Mice, Inbred BALB C | 2 | 2017 | 834 | 0.250 |
Why?
|
| Models, Biological | 1 | 2009 | 1097 | 0.250 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2023 | 36 | 0.240 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2003 | 12 | 0.240 |
Why?
|
| Depression | 1 | 2010 | 765 | 0.230 |
Why?
|
| Particle Size | 2 | 2015 | 371 | 0.230 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 3 | 2013 | 70 | 0.230 |
Why?
|
| Macaca mulatta | 1 | 2023 | 205 | 0.230 |
Why?
|
| Biocompatible Materials | 2 | 2015 | 135 | 0.210 |
Why?
|
| Aldosterone | 1 | 2001 | 15 | 0.210 |
Why?
|
| Diffusion | 2 | 2013 | 71 | 0.210 |
Why?
|
| Amines | 1 | 2021 | 29 | 0.200 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2021 | 76 | 0.200 |
Why?
|
| Polyesters | 1 | 2021 | 43 | 0.200 |
Why?
|
| Male | 8 | 2021 | 23363 | 0.200 |
Why?
|
| Delayed-Action Preparations | 1 | 2021 | 99 | 0.200 |
Why?
|
| Cerebrospinal Fluid | 1 | 2020 | 16 | 0.190 |
Why?
|
| Cerebral Ventricles | 1 | 2020 | 26 | 0.190 |
Why?
|
| Micelles | 1 | 2020 | 70 | 0.180 |
Why?
|
| Receptors, CXCR4 | 2 | 2016 | 33 | 0.180 |
Why?
|
| Liposomes | 1 | 2020 | 96 | 0.180 |
Why?
|
| Child | 3 | 2023 | 3888 | 0.180 |
Why?
|
| Infratentorial Neoplasms | 1 | 2018 | 4 | 0.180 |
Why?
|
| Ependymoma | 1 | 2018 | 4 | 0.180 |
Why?
|
| Azacitidine | 1 | 2018 | 14 | 0.180 |
Why?
|
| Time Factors | 3 | 2015 | 3163 | 0.170 |
Why?
|
| Viscosity | 2 | 2015 | 36 | 0.170 |
Why?
|
| Elasticity | 2 | 2015 | 37 | 0.170 |
Why?
|
| Neural Stem Cells | 2 | 2016 | 45 | 0.170 |
Why?
|
| Sonication | 1 | 2018 | 12 | 0.160 |
Why?
|
| Nootropic Agents | 1 | 2017 | 8 | 0.160 |
Why?
|
| Levonorgestrel | 1 | 2017 | 9 | 0.160 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2021 | 317 | 0.160 |
Why?
|
| Ovariectomy | 1 | 2017 | 92 | 0.160 |
Why?
|
| Memory, Short-Term | 1 | 2017 | 52 | 0.160 |
Why?
|
| Cell Self Renewal | 1 | 2017 | 12 | 0.160 |
Why?
|
| Optical Phenomena | 1 | 2017 | 5 | 0.160 |
Why?
|
| Gene Products, tat | 1 | 2017 | 13 | 0.160 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2018 | 390 | 0.150 |
Why?
|
| Stem Cell Transplantation | 1 | 2016 | 64 | 0.140 |
Why?
|
| Fluorescent Dyes | 1 | 2018 | 184 | 0.140 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2017 | 151 | 0.140 |
Why?
|
| Centrifugation | 1 | 2015 | 8 | 0.140 |
Why?
|
| MAP Kinase Signaling System | 2 | 2017 | 193 | 0.140 |
Why?
|
| Acrylamides | 1 | 2015 | 11 | 0.140 |
Why?
|
| Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2015 | 32 | 0.140 |
Why?
|
| Chromatography, Gel | 1 | 2015 | 61 | 0.140 |
Why?
|
| Rheology | 1 | 2015 | 55 | 0.140 |
Why?
|
| Avidin | 1 | 2014 | 9 | 0.130 |
Why?
|
| Half-Life | 1 | 2014 | 63 | 0.130 |
Why?
|
| HEK293 Cells | 1 | 2017 | 527 | 0.130 |
Why?
|
| Isotope Labeling | 1 | 2014 | 48 | 0.130 |
Why?
|
| Injections, Intravenous | 1 | 2015 | 129 | 0.130 |
Why?
|
| Biotin | 1 | 2014 | 42 | 0.130 |
Why?
|
| DNA Primers | 3 | 2010 | 276 | 0.130 |
Why?
|
| Brain Injuries | 1 | 2016 | 129 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 392 | 0.130 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2015 | 250 | 0.130 |
Why?
|
| Glycoproteins | 1 | 2015 | 193 | 0.130 |
Why?
|
| Ligands | 1 | 2015 | 390 | 0.130 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 200 | 0.130 |
Why?
|
| Peptide Fragments | 1 | 2015 | 319 | 0.120 |
Why?
|
| Gene Expression | 2 | 2016 | 739 | 0.120 |
Why?
|
| Cognition | 1 | 2017 | 414 | 0.120 |
Why?
|
| Sepharose | 1 | 2013 | 6 | 0.120 |
Why?
|
| Heart | 1 | 2015 | 226 | 0.120 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2013 | 96 | 0.120 |
Why?
|
| Cell Nucleus Shape | 1 | 2013 | 5 | 0.120 |
Why?
|
| Neostriatum | 1 | 2013 | 22 | 0.120 |
Why?
|
| Cyclopentanes | 1 | 2013 | 8 | 0.120 |
Why?
|
| Dithiazanine | 1 | 2013 | 1 | 0.120 |
Why?
|
| Viral Proteins | 1 | 2015 | 260 | 0.120 |
Why?
|
| Molecular Weight | 1 | 2013 | 177 | 0.120 |
Why?
|
| Quinolines | 1 | 2013 | 33 | 0.120 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2013 | 30 | 0.120 |
Why?
|
| Mice, Nude | 1 | 2013 | 216 | 0.120 |
Why?
|
| Feasibility Studies | 1 | 2015 | 439 | 0.120 |
Why?
|
| Pancreatic Neoplasms | 1 | 2016 | 288 | 0.110 |
Why?
|
| Testis | 1 | 2013 | 138 | 0.110 |
Why?
|
| Survival Rate | 1 | 2015 | 659 | 0.110 |
Why?
|
| Base Sequence | 3 | 2010 | 1244 | 0.110 |
Why?
|
| Blotting, Western | 2 | 2010 | 535 | 0.110 |
Why?
|
| Aging | 1 | 2017 | 683 | 0.110 |
Why?
|
| Cell Differentiation | 1 | 2017 | 1232 | 0.100 |
Why?
|
| DNA Damage | 1 | 2013 | 273 | 0.100 |
Why?
|
| Cyclin B1 | 1 | 2010 | 9 | 0.100 |
Why?
|
| Spermatids | 1 | 2010 | 12 | 0.100 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2010 | 35 | 0.100 |
Why?
|
| Estrogen Receptor beta | 1 | 2010 | 22 | 0.100 |
Why?
|
| Estrogen Receptor alpha | 1 | 2010 | 42 | 0.100 |
Why?
|
| Emulsions | 1 | 2013 | 425 | 0.100 |
Why?
|
| Receptor, trkA | 1 | 2010 | 3 | 0.100 |
Why?
|
| Glucuronic Acid | 1 | 2010 | 16 | 0.090 |
Why?
|
| Hexuronic Acids | 1 | 2010 | 20 | 0.090 |
Why?
|
| Osmosis | 1 | 2009 | 5 | 0.090 |
Why?
|
| Polyvinyls | 1 | 2010 | 18 | 0.090 |
Why?
|
| Microspheres | 1 | 2010 | 49 | 0.090 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2010 | 42 | 0.090 |
Why?
|
| Microscopy, Atomic Force | 1 | 2009 | 28 | 0.090 |
Why?
|
| Alginates | 1 | 2010 | 35 | 0.090 |
Why?
|
| Coronary Stenosis | 1 | 2009 | 31 | 0.090 |
Why?
|
| Solubility | 1 | 2009 | 167 | 0.090 |
Why?
|
| Female | 4 | 2018 | 26652 | 0.090 |
Why?
|
| Elastin | 1 | 2008 | 5 | 0.090 |
Why?
|
| Glass | 1 | 2008 | 22 | 0.090 |
Why?
|
| Neuronal Plasticity | 1 | 2010 | 125 | 0.090 |
Why?
|
| Behavior, Animal | 1 | 2010 | 195 | 0.080 |
Why?
|
| Aorta | 1 | 2008 | 89 | 0.080 |
Why?
|
| Exons | 1 | 2008 | 176 | 0.080 |
Why?
|
| Cell Line | 2 | 2003 | 1922 | 0.080 |
Why?
|
| Endothelium, Vascular | 1 | 2008 | 148 | 0.080 |
Why?
|
| Extracellular Matrix | 1 | 2008 | 133 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 485 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 1 | 2008 | 371 | 0.080 |
Why?
|
| Models, Statistical | 1 | 2008 | 295 | 0.070 |
Why?
|
| RNA, Messenger | 2 | 2003 | 1366 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 722 | 0.070 |
Why?
|
| Stress, Psychological | 1 | 2010 | 383 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 1317 | 0.060 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2003 | 23 | 0.060 |
Why?
|
| Membrane Transport Proteins | 1 | 2023 | 104 | 0.060 |
Why?
|
| Phosphoproteins | 1 | 2003 | 201 | 0.050 |
Why?
|
| Neoplasm Proteins | 1 | 2023 | 250 | 0.050 |
Why?
|
| 3-Hydroxysteroid Dehydrogenases | 1 | 2001 | 1 | 0.050 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 1 | 2001 | 4 | 0.050 |
Why?
|
| Chromatography, Thin Layer | 1 | 2001 | 14 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2001 | 133 | 0.050 |
Why?
|
| Fourth Ventricle | 1 | 2018 | 2 | 0.040 |
Why?
|
| Infusions, Intraventricular | 1 | 2018 | 6 | 0.040 |
Why?
|
| Disease Progression | 1 | 2021 | 744 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 1104 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 1068 | 0.040 |
Why?
|
| Spatial Memory | 1 | 2017 | 7 | 0.040 |
Why?
|
| Rats, Inbred F344 | 1 | 2017 | 53 | 0.040 |
Why?
|
| Maze Learning | 1 | 2017 | 51 | 0.040 |
Why?
|
| Neurofibromin 1 | 1 | 2017 | 9 | 0.040 |
Why?
|
| Frontal Lobe | 1 | 2017 | 61 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2021 | 580 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2018 | 242 | 0.040 |
Why?
|
| Injections, Intraventricular | 1 | 2016 | 13 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2018 | 312 | 0.040 |
Why?
|
| Stereotaxic Techniques | 1 | 2016 | 18 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 358 | 0.040 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2016 | 31 | 0.040 |
Why?
|
| Gelatin | 1 | 2015 | 25 | 0.040 |
Why?
|
| Solutions | 1 | 2015 | 56 | 0.040 |
Why?
|
| Methacrylates | 1 | 2015 | 35 | 0.040 |
Why?
|
| Serum Albumin, Bovine | 1 | 2015 | 34 | 0.040 |
Why?
|
| Injections | 1 | 2015 | 64 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2018 | 775 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2016 | 157 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2016 | 137 | 0.030 |
Why?
|
| Electric Stimulation | 1 | 2015 | 109 | 0.030 |
Why?
|
| Myocytes, Cardiac | 1 | 2015 | 68 | 0.030 |
Why?
|
| Chemotaxis | 1 | 2015 | 46 | 0.030 |
Why?
|
| Cell Count | 1 | 2015 | 117 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2015 | 222 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 170 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 2015 | 129 | 0.030 |
Why?
|
| Cattle | 1 | 2015 | 291 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 1779 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2017 | 789 | 0.030 |
Why?
|
| Cell Movement | 1 | 2016 | 390 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2015 | 341 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 227 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2015 | 342 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2018 | 1686 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2017 | 566 | 0.030 |
Why?
|
| Fluorescence | 1 | 2013 | 84 | 0.030 |
Why?
|
| Swine | 1 | 2013 | 296 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 347 | 0.030 |
Why?
|
| Biomarkers | 1 | 2015 | 1003 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2015 | 1998 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2010 | 207 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2010 | 125 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2010 | 181 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2010 | 325 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2018 | 3966 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 1472 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2016 | 2709 | 0.020 |
Why?
|